Ionis Pharmaceuticals Revenue 2006-2019 | IONS

Ionis Pharmaceuticals annual/quarterly revenue history and growth rate from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Ionis Pharmaceuticals revenue for the quarter ending September 30, 2019 was $0.168B, a 15.47% increase year-over-year.
  • Ionis Pharmaceuticals revenue for the twelve months ending September 30, 2019 was $0.821B, a 42.7% increase year-over-year.
  • Ionis Pharmaceuticals annual revenue for 2018 was $0.6B, a 16.63% increase from 2017.
  • Ionis Pharmaceuticals annual revenue for 2017 was $0.514B, a 37.93% increase from 2016.
  • Ionis Pharmaceuticals annual revenue for 2016 was $0.373B, a 31.4% increase from 2015.
Ionis Pharmaceuticals Annual Revenue
(Millions of US $)
2018 $600
2017 $514
2016 $373
2015 $284
2014 $214
2013 $147
2012 $102
2011 $99
2010 $108
2009 $122
2008 $107
2007 $58
2006 $15
2005 $40
Ionis Pharmaceuticals Quarterly Revenue
(Millions of US $)
Q3 2019 $168
Q2 2019 $164
Q1 2019 $297
Q4 2018 $192
Q3 2018 $145
Q2 2018 $118
Q1 2018 $144
Q4 2017 $168
Q3 2017 $118
Q2 2017 $112
Q1 2017 $116
Q4 2016 $187
Q3 2016 $111
Q2 2016 $38
Q1 2016 $37
Q4 2015 $52
Q3 2015 $49
Q2 2015 $120
Q1 2015 $63
Q4 2014 $85
Q3 2014 $44
Q2 2014 $57
Q1 2014 $28
Q4 2013 $42
Q3 2013 $24
Q2 2013 $38
Q1 2013 $43
Q4 2012 $20
Q3 2012 $12
Q2 2012 $47
Q1 2012 $23
Q4 2011 $32
Q3 2011 $21
Q2 2011 $25
Q1 2011 $21
Q4 2010 $26
Q3 2010 $29
Q2 2010 $24
Q1 2010 $30
Q4 2009 $32
Q3 2009 $27
Q2 2009 $31
Q1 2009 $32
Q4 2008 $30
Q3 2008 $29
Q2 2008 $30
Q1 2008 $18
Q4 2007 $13
Q3 2007 $39
Q2 2007 $4
Q1 2007 $2
Q4 2006 $2
Q3 2006 $3
Q2 2006 $4
Q1 2006 $5
Q4 2005 $15
Q3 2005 $7
Q2 2005 $11
Q1 2005 $7
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $7.880B $1.123B
Ionis Pharmaceuticals, Inc. is a RNA-targeted drug discovery and development company which focuses on developing drugs for severe and rare diseases. Ionis Pharmaceuticals, Inc., formerly known as Isis Pharmaceuticals, Inc., is headquartered in Carlsbad, California.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $64.662B 37.40
Takeda Pharmaceutical (TAK) Japan $56.763B 10.06
Astellas Pharma (ALPMY) Japan $30.561B 15.26
Eisai (ESALY) Japan $22.232B 42.86
UCB SA (UCBJF) Belgium $18.867B 0.00
Grifols, S.A (GRFS) Spain $16.783B 21.99
Merck (MKGAF) Germany $16.058B 21.91
Ono Pharmaceutical (OPHLF) Japan $11.311B 24.18
Neurocrine Biosciences (NBIX) United States $8.671B 240.90
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.449B 0.00
Catalent (CTLT) United States $8.056B 33.15
Jazz Pharmaceuticals (JAZZ) Ireland $6.545B 7.98
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.877B 0.00
Orion OYJ (ORINY) Finland $5.871B 30.12
IPSEN SA ADR (IPSEY) France $5.799B 0.00
STADA ARZNEIMI (STDAF) Germany $5.543B 0.00
Hypermarcas (HYPMY) Brazil $4.856B 14.77
United Therapeutics (UTHR) United States $4.643B 0.00
Nektar Therapeutics (NKTR) United States $3.766B 0.00
Evotec AG (EVTCY) Germany $3.729B 60.18
Arrowhead Pharmaceuticals (ARWR) United States $3.666B 68.04
FibroGen (FGEN) United States $3.618B 106.33
PTC Therapeutics (PTCT) United States $3.349B 0.00
Sage Therapeutics (SAGE) United States $3.298B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.796B 11.31
ChemoCentryx (CCXI) United States $2.673B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.052B 0.00
Xencor (XNCR) United States $1.899B 77.56
Pacira Pharmaceuticals (PCRX) United States $1.897B 51.88
Ironwood Pharmaceuticals (IRWD) United States $1.751B 21.29
Heron Therapeutics (HRTX) United States $1.663B 0.00
Tilray (TLRY) Canada $1.597B 0.00
Corcept Therapeutics (CORT) United States $1.552B 17.36
Endo (ENDP) Ireland $1.440B 2.66
USANA Health Sciences (USNA) United States $1.416B 14.87
CLINIGEN GP (CLIGF) United Kingdom $1.392B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.349B 0.00
Zogenix (ZGNX) United States $1.153B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.152B 16.04
Akebia Therapeutics (AKBA) United States $1.050B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.017B 31.51
Portola Pharmaceuticals (PTLA) United States $0.974B 0.00
Karyopharm Therapeutics (KPTI) United States $0.903B 0.00
Aerie Pharmaceuticals (AERI) United States $0.870B 0.00
Radius Health (RDUS) United States $0.825B 0.00
Collegium Pharmaceutical (COLL) United States $0.757B 0.00
ImmunoGen (IMGN) United States $0.695B 0.00
Flexion Therapeutics (FLXN) United States $0.623B 0.00
Molecular Templates (MTEM) United States $0.608B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.528B 0.00
TherapeuticsMD (TXMD) United States $0.483B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.480B 58.25
Ardelyx (ARDX) United States $0.450B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.440B 18.99
Translate Bio (TBIO) United States $0.435B 0.00
Innate Pharma SA (IPHYF) France $0.423B 0.00
Organogenesis Holdings (ORGO) United States $0.406B 0.00
Calithera Biosciences (CALA) United States $0.391B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.388B 0.00
Siga Technologies (SIGA) United States $0.379B 8.67
BioCryst Pharmaceuticals (BCRX) United States $0.375B 0.00
Indivior (INVVY) United States $0.373B 2.22
DURECT (DRRX) United States $0.369B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.364B 0.00
Lannett Co Inc (LCI) United States $0.363B 5.84
Harpoon Therapeutics (HARP) United States $0.363B 0.00
Recro Pharma (REPH) United States $0.349B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.341B 0.00
Concert Pharmaceuticals (CNCE) United States $0.323B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.323B 0.00
Rafael Holdings (RFL) United States $0.308B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.295B 0.00
OptiNose (OPTN) United States $0.267B 0.00
KalVista Pharmaceuticals (KALV) United States $0.245B 0.00
Ocular Therapeutix (OCUL) United States $0.238B 0.00
MEI Pharma (MEIP) United States $0.229B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.222B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.194B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.188B 0.00
Taiwan Liposome (TLC) Taiwan $0.186B 0.00
Nature's Sunshine Products (NATR) United States $0.184B 31.67
Matinas Biopharma Holdings (MTNB) United States $0.176B 0.00
Jounce Therapeutics (JNCE) United States $0.176B 2.35
IMV INC (IMV) Canada $0.135B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.122B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.114B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.113B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.107B 0.00
CannTrust Holdings (CTST) Canada $0.106B 0.00
Xeris Pharmaceuticals (XERS) United States $0.104B 0.00
Redhill Biopharma (RDHL) Israel $0.103B 0.00
Aquestive Therapeutics (AQST) United States $0.100B 0.00
Otonomy (OTIC) United States $0.100B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.090B 0.00
VAXART, INC (VXRT) United States $0.079B 0.00
Neos Therapeutics (NEOS) United States $0.078B 0.00
Champions Oncology (CSBR) United States $0.075B 0.00
CV Sciences (CVSI) United States $0.073B 0.00
Infinity Pharmaceuticals (INFI) United States $0.072B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.067B 0.00
Onconova Therapeutics (ONTX) United States $0.067B 0.00
MediWound (MDWD) Israel $0.065B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.063B 18.91
RENEURON GP (RNUGF) United Kingdom $0.061B 0.00
CTI BioPharma (CTIC) United States $0.060B 0.00
Nivalis Therapeutics (ALPN) United States $0.059B 0.00
SCYNEXIS (SCYX) United States $0.057B 0.00
IsoRay (ISR) United States $0.056B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.053B 0.00
Aclaris Therapeutics (ACRS) United States $0.051B 0.00
Natural Alternatives (NAII) United States $0.051B 23.13
Opiant Pharmaceuticals (OPNT) United States $0.050B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.045B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.044B 0.00
AgeX Therapeutics (AGE) United States $0.044B 0.00
Forward Pharma (FWP) Denmark $0.043B 0.00
Iterum Therapeutics (ITRM) Ireland $0.041B 0.00
Mannatechorporated (MTEX) United States $0.038B 0.00
PolarityTE (PTE) United States $0.037B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.034B 0.00
Jaguar Animal Health (JAGX) United States $0.032B 0.00
ElectroCore (ECOR) United States $0.028B 0.00
Biomerica (BMRA) United States $0.027B 0.00
PharmAthene (ALT) United States $0.026B 0.00
China SXT Pharmaceuticals (SXTC) China $0.025B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.025B 0.00
Vical (BBI) United States $0.024B 0.00
ProPhase Labs (PRPH) United States $0.020B 0.00
India Globalization Capital (IGC) United States $0.019B 0.00
Cardiome Pharma (CORV) Canada $0.019B 0.00
Bio-Path Holdings (BPTH) United States $0.017B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.017B 0.00
Shineco (TYHT) China $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.015B 0.00
Lipocine (LPCN) United States $0.013B 0.00
Cyanotech (CYAN) United States $0.013B 0.00
Heat Biologics (HTBX) United States $0.013B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.013B 0.00
HANCOCK JAFFE (HJLI) United States $0.013B 0.00
Novan (NOVN) United States $0.012B 0.00
Hemispherx BioPharma (AIM) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.007B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
RXi Pharmaceuticals (PHIO) United States $0.002B 0.00
Can-Fite Biopharma (CANF) Israel $0.002B 0.00